Paper TrailKOREA
Why Korean and U.S. stocks moved, checked against filings

CoreWeave up 25%, AXT and Azenta follow: same reason?

CoreWeave (CRWV) rose 24.71% after its earnings and lifted the Nasdaq. Azenta (AZTA) rose on its own results, while AXT (AXTI) gained with no company filing at all.

CoreWeave up 25%, AXT and Azenta follow: same reason?

Published 2026-11-12 08:26 KST. All closes are regular-session closes on Nov. 11 (U.S. time); news headline times are Korea time. The three stocks here each closed up 19% or more.

Seoul — U.S. stocks rose on Nov. 11: the S&P 500 gained 1.31%, the Nasdaq Composite 1.6% and the Russell 2000 (small-cap index) 0.88%. CoreWeave (CRWV), an AI cloud provider, drove the day with a 24.71% jump after earnings. Azenta (AZTA) rose 20.8% on its own results. AXT (AXTI) gained 19.49%, but the company filed nothing, and the only explanation in the news is a broad tech rebound. Our own weekly market notes say last week was dominated by AI and semiconductor bubble fears, so part of this day looks like a bounce from that selling.

At a glance

Stock Why it rose Nature Evidence Heat What to check next
CoreWeave (CRWV) +24.71% Nov. 10 quarterly results eased AI worries Substantive, one-off Filing confirmed 0/4 (normal) Revenue and guidance in the press release; whether the $4B loan report shows up in a filing
Azenta (AZTA) +20.8% Fiscal Q4 results and outlook Substantive, one-off Filing confirmed 0/4 (normal) Whether it holds its 52-week-high close
AXT (AXTI) +19.49% Rode a tech-sector rebound Expectation Reports only 0/4 (normal) Whether trading value holds the next day

CoreWeave rose 25% after earnings, as AI worries eased

CoreWeave, Inc. (CRWV) rose because of the quarterly results it released on Nov. 10. According to an 8-K (a current report to the SEC), Item 2.02 (results of operations), the company reported results for the quarter ended Sept. 30. The 8-K itself carries no numbers; they are in the attached press release (Exhibit 99.1). The Wall Street Journal wrote that the CoreWeave update "eases some AI concerns", and Yahoo Finance said the results drove a broad tech rally. Headlines also said Oracle and AMD rose with it.

The stock had fallen a long way first. It slid from $81.58 on Oct. 8 to $43.66 on Nov. 5, recovered to $48.98 on Nov. 9, and dipped slightly on the 10th. The $60.77 close is 24.1% above two days earlier and 25.5% above five trading days earlier, yet still 25.5% below Oct. 8. Dollar volume was about $9.6 billion, roughly 29% of the $33.5 billion market cap, and the day added about $6.6 billion in value.

Bloomberg also reported that CoreWeave plans to raise at least $4 billion in a high-grade loan. The headline gives no terms, and no company filing confirms it yet. Several Form 144 (notice of proposed insider sale) and Form 4 (insider trade) filings appeared between Nov. 5 and 10. We did not check their contents here, and nothing links them to the rise.

On the heat check, the overheating signal count is 0/4 (normal): RSI 54.6, 8.4% above the 20-day average, volume 2.2 times the 20-day average. The stock is 32.1% below its 200-day line and 56.0% below its 52-week high. It passed 1 of 6 earnings-health tests, revenue growth (168.3%), and failed profitability, free cash flow, debt, ROE and PER. The filing is neutral.

To judge whether this lasts, check two things. One is whether the revenue and guidance in Exhibit 99.1 are strong enough to support the rebound. The other is whether the company confirms the $4 billion loan in an 8-K, and whether trading value stays near $9 billion the next day.

Azenta hit a 52-week high on Q4 results and outlook

Azenta, Inc. (AZTA) rose 20.8% on fiscal fourth-quarter results and closed at a 52-week high. An 8-K (Item 2.02) shows it reported results on Nov. 10 for the quarter and year ended Sept. 30. Investing.com ran a headline saying Azenta topped Q4 estimates. StockStory's headline said commercial execution and new gene synthesis capabilities drive the outlook. Jefferies was also reported to have raised its price target.

The price move is far bigger than the growth, though: the revenue growth figure in our checks is 5.1%. The $48.90 close is 19.4% above two days earlier, 24.9% above five days earlier and 35.8% above Oct. 8. Dollar volume was about $121 million, 5.7% of the $2.14 billion market cap.

The overheating count is 0/4 (normal), but the readings run high: RSI 72.4, 27.6% above the 20-day average, volume 2.7 times normal, and 72.4% above the 200-day line. It passed 3 of 6 earnings-health tests (positive free cash flow, debt, revenue growth) and failed profitability, ROE and PER. The filing is positive.

Watch whether the stock holds this closing high the next session. Also check in Exhibit 99.1 how much of the revenue gain gene synthesis explains, to tell a one-off surprise from a continuing trend.

AXT rose with no company news, only a tech rebound

AXT, Inc. (AXTI) rose 19.49% with no company filing behind it. The only recent SEC documents are a SCHEDULE 13G/A on Nov. 6 and a SCHEDULE 13G on Nov. 9, both ownership reports from holders of more than 5%, unrelated to the rise. The reports point to the market. Seeking Alpha's headline said AXT "jumps 23% amid broad technology rally" (intraday), GuruFocus tied the same day to a tech rally, and Business Upturn grouped it with CoreWeave.

The stock had been volatile. It fell 22.76% on Nov. 5 to $36.72 and another 8.39% on the 10th. The $46.97 close is 1.2% below five days earlier and 34.5% below Oct. 8. Dollar volume was about $691 million, 22% of the $3.08 billion market cap.

The overheating count is 0/4 (normal): RSI 46.4, 9.0% below the 20-day average, volume 1.3 times normal. It is 66.6% below its 52-week high and 28.6% below its 200-day line. It passed 3 of 5 earnings-health tests (profitable, debt, revenue growth of 162.6%) and failed ROE and PER (95.9).

Two things show whether this holds. Because the move came from sector mood rather than company news, first see if CoreWeave holds the next day. Then see how much of the Nov. 5 drop ($36.72) has been recovered and whether trading value stays near this level.

Filings and reports checked

  • 2026-11-10 CoreWeave 8-K (2.02, 9.01): https://www.sec.gov/Archives/edgar/data/1769628/000176962826000461/crwv-20261110.htm
  • 2026-11-10 Azenta 8-K (2.02, 9.01): https://www.sec.gov/Archives/edgar/data/933974/000162828026072809/azta-20261110.htm
  • 2026-11-12 Bloomberg: "CoreWeave Plans to Raise at Least $4 Billion in High-Grade Loan"
  • 2026-11-12 WSJ: "U.S. Stocks Gain After CoreWeave Update Eases Some AI Concerns"
  • 2026-11-12 Business Upturn: "US Stock Movers: CoreWeave Surges 24% as Azenta and AXT Also Post Sharp Gains"

FAQ

Why did CoreWeave rise? It reported quarterly results on Nov. 10, and reports said AI worries eased afterward.

Which filing backs it up? The 8-K Item 2.02 (results) filed on Nov. 10 by CoreWeave and by Azenta. AXT has no company filing behind its move.

What should I check next? Whether CoreWeave's loan plan is confirmed in an 8-K, and each stock's trading value the next session.

What happened to the stocks we covered earlier

Closing moves through Nov. 11 for the eight stocks from our previous articles. The sample is small, so it is hard to read as a pattern, and stocks with the same label ended up in different places.

Stock Verdict then Close then → Nov. 11 Change
Firefly Aerospace Inc. (FLY) Reports 20.76 → 26.61 +28.2%
JFrog Ltd. (FROG) Earnings 100.98 → 109.51 +8.4%
Karman Holdings Inc. (KRMN) Earnings 45.61 → 44.69 -2.0%
AppLovin Corporation (APP) Earnings 356.10 → 404.77 +13.7%
Encore Capital Group, Inc. (ECPG) Earnings 126.17 → 112.35 -11.0%
ADMA Biologics, Inc. (ADMA) Earnings 13.21 → 13.19 -0.2%
Rhythm Pharmaceuticals, Inc. (RYTM) Reports 110.68 → 112.16 +1.3%
Kyndryl Holdings, Inc. (KD) Earnings 16.84 → 17.13 +1.7%

Of the six earnings-based names, three rose and three fell. Both report-based names rose, but by very different amounts, +28.2% and +1.3%. A filing or earnings release does not reliably mean a stock keeps rising.

FAQ

Why did CoreWeave, Inc. stock go up?

Nov. 10 quarterly results eased AI worries. Evidence: Filing confirmed. What to check next: 0/4 (normal).

Why did Azenta, Inc. stock go up?

Fiscal Q4 results and outlook. Evidence: Filing confirmed. What to check next: 0/4 (normal).

Why did AXT, Inc. stock go up?

Rode a tech-sector rebound. Evidence: Reports only. What to check next: 0/4 (normal).

← Latest · Daily movers archive